A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles

Nature Medicine

Volumn 9, Issue 9, 2003, Pages 1209-1213

  Polack, Fernando P ^a,b   Hoffman, Scott J ^a,b   Crujeiras, Gonzalo ^c   Griffin, Diane E ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Division of Virology/Immunology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT FIXING ANTIBODY; DNA VACCINE; HEMAGGLUTININ; INACTIVATED VACCINE; MEASLES VACCINE; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY AFFINITY; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; COMPLEMENT DEPOSITION; COMPLEMENT FIXATION; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN CELL; IMMUNE COMPLEX DEPOSITION; IMMUNE COMPLEX DISEASE; IMMUNITY; IMMUNIZATION; MEASLES; MEASLES VIRUS; MONKEY; NONHUMAN; PRIORITY JOURNAL; RECIPIENT;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY AFFINITY; COMPLEMENT SYSTEM PROTEINS; HEMAGGLUTININS; MACACA MULATTA; MEASLES; MEASLES VACCINE; MEASLES VIRUS; NEUTRALIZATION TESTS; VACCINES, ATTENUATED; VACCINES, DNA;

ANIMALIA; MEASLES VIRUS; RNA VIRUSES;

EID: 0141684561     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm918     Document Type: Article

References (30)

1. Carter, C.H. et al. Serologic response of children to inactivated measles vaccine. JAMA 179, 848-853 (1962).
2. Nader, P.R., Honwitz, M.S. & Rousseau, J. Atypical exanthem following exposure to natural measles: eleven cases in children previously inoculated with killed vaccine. J. Pediatr. 72, 22-28 (1968).
3. Gans, H.A. et al. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. JAMA 280, 527-532 (1998).
4. Halsey, N.A. et al. Response to measles vaccine in Haitian infants 6 to 12 months old. Influence of maternal antibodies, malnutrition, and concurrent illnesses. N. Engl. J. Med. 313, 544-549 (1985).
5. Polack, F.P. et al. Production of atypical measles in rhesus macaques: evidence for disease mediated by IC formation and eosinophils in the presence of fusion-inhibiting antibodies. Nat. Med. 5, 629-634 (1999).
6. Walport, M.J., Davies, K.A., Morley, B.J. & Botto, M. Complement deficiency and autoimmunity. Ann. NY Acad. Sci. 815, 267-281 (1997).
7. Carter, P.M. IC disease. Ann. Rheum. Dis. 32, 265-271 (1973).
8. Polack, F.P. et al. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Nat. Med. 6, 776-781 (2000).
9. Erlenhofer, C., Duprex, W.P., Rima, B.K., ter Meulen, V. & Schneider-Schaulies, J. Analysis of receptor (CD46, CD150) usage by measles virus. J. Gen. Virol. 83, 1431-1436 (2002).
10. Dorig, R.E., Marcil, A., Chopra, A. & Richardson, C.D. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75, 295-305 (1993).
11. Tatsuo, H., Ono, N., Tanaka, K. & Yanagi, Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406, 893-897 (2000).
12. Santiago, C., Bjorling, E., Stehle, T. & Casanovas, J.L. Distinct kinetics for binding of the CD46 and SLAM receptors to overlapping sites in the measles virus hemagglutinin protein. J. Biochem. Chem. 277, 32294-32301 (2002).
13. Grady, L.J. & Kinch, W. Two monoclonal antibodies against La Crosse virus show host-dependent neutralizing activity. J. Gen. Virol. 66, 2773-2776 (1985).
14. Kjellen, L. A hypothesis accounting for the effect of host cell on neutralization-resistant virus. J. Gen. Virol. 66, 2279-2283 (1985).
15. Ruppach, H. et al. Human immunodeficiency virus (HIV)-positive sera obtained shortly after seroconversion neutralize autologous HIV type 1 isolates on primary macrophages but not on lymphocytes. J. Virol. 74, 5403-5411 (2000).
16. Ziola, B., Lund, G., Meurman, O. & Salmi, A. Circulating ICs in patients with acute rubella and measles virus infections. Infect. Immun. 41, 578-583 (1983).
17. Devey, M.E. & Steward, M.W. The induction of chronic antigen-antibody complex disease in selectively bred mice producing either high or low affinity antibodies to protein antigens. Immunology 41, 303-311 (1980).
18. Devey, M.E., Bleasdale-Barr, K.M., Bird, P. & Amlot, P.L. Antibodies of different human IgG subclasses show distinct patterns of affinity maturation after immunization with keyhole limpet hemocyanin. Immunology 70, 168-174 (1990).
19. Steward, M.W. Chronic IC disease in mice: the role of antibody affinity. Clin. Exp. Immunol. 38, 414-423 (1979).
20. Devey, M.E., Bleasdale, K., Stanley, C. & Steward, M.W. Failure of affininty maturation leads to increased susceptibility to IC glomerulonephritis. Immunology 52, 377-383 (1984).
21. Soothill, J.F. & Steward, M.W. The immunopathological significance of the heterogeneity of antibody affinity. Clin. Exp. Immunol. 9, 193-199 (1971).
22. Alonso, A., Bayon, Y., Mateos, J.J. & Sanchez Crespo, M. Signaling by leukocyte chemoattractant and Fcγ receptors in IC tissue injury. Lab. Invest. 78, 377-392 (1998).
23. Voice, J.K. & Lachmann, P.J. Neutrophil Fc gamma and complement receptors involved in binding soluble IgG ICs and in specific granule release induced by soluble IgG ICs. Eur. J. Immunol. 27, 2514-2523 (1997).
24. Klasse, P.J. & Sattentau, Q.J. Occupancy and mechanism in antibody-mediated neutralization of animal viruses, J. Gen. Virol. 83, 2091-2108 (2002).
25. MacLennan, I.C.M. Germinal centers. Ann. Rev. Immunol. 12,117-139 (1994).
26. Walker, L.S., Gulbranson-Judge, A., Flynn, S., Brocker, T. & Lane, P.J. Co-stimulation and selection for T-cell help for germinal centres: the role of CD28 and OX40. Immunol. Today 21, 333-337 (2000).
27. Steward, M.W., Stanley, C.M., Dimarchi, R., Mulcahy, G. & Doel, T.R. High-affinity antibody induced by immunization with a synthetic peptide is associated with protection of cattle against foot-and-mouth disease. Immunology 72, 99-103 (1991).
28. Chargelegue, D., Stanley, C.M., O'Toole, C.M., Colvin, B.T. & Steward, M.W. The affinity of IgG antibodies to gag p24 and p17 in HIV-infected patients correlates with disease progression. Clin. Exp. Immunol. 99, 175-181 (1995).
29. Olszewska, W., Obeid, O.E. & Steward, M.W. Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity. Virology 272, 98-105 (2000).
30. Kalinke, U. et al. The role of somatic mutation in the generation of the protective humoral immune response against vesicular stomatitis virus. Immunity 5, 639-652 (1996).